Fate Therapeutics Inc (FATE)
5.43
+0.03
(+0.56%)
USD |
NASDAQ |
Jul 26, 16:00
5.43
0.00 (0.00%)
After-Hours: 20:00
Fate Therapeutics Price: 5.43 for July 26, 2024
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Jul 25, 2024 | 5.19 | 5.68 | 5.18 | 5.40 | 1.467M |
| Jul 24, 2024 | 5.44 | 5.72 | 5.16 | 5.18 | 2.906M |
| Jul 23, 2024 | 4.53 | 5.630 | 4.52 | 5.57 | 3.373M |
| Jul 22, 2024 | 4.33 | 4.585 | 4.164 | 4.56 | 1.430M |
| Jul 19, 2024 | 4.30 | 4.39 | 4.17 | 4.27 | 1.004M |
| Jul 18, 2024 | 4.43 | 4.58 | 4.22 | 4.31 | 2.614M |
| Jul 17, 2024 | 4.407 | 4.74 | 4.28 | 4.46 | 3.450M |
| Jul 16, 2024 | 3.92 | 5.00 | 3.92 | 4.55 | 7.656M |
| Jul 15, 2024 | 3.67 | 3.91 | 3.55 | 3.89 | 2.332M |
| Jul 12, 2024 | 3.44 | 3.71 | 3.39 | 3.61 | 1.996M |
| Jul 11, 2024 | 3.22 | 3.46 | 3.22 | 3.40 | 2.397M |
| Jul 10, 2024 | 3.17 | 3.195 | 3.06 | 3.12 | 938154.0 |
| Jul 09, 2024 | 3.10 | 3.165 | 3.025 | 3.13 | 1.322M |
| Jul 08, 2024 | 3.19 | 3.34 | 3.11 | 3.12 | 983393.0 |
| Jul 05, 2024 | 3.17 | 3.17 | 3.09 | 3.17 | 1.168M |
| Jul 03, 2024 | 3.21 | 3.355 | 3.14 | 3.16 | 581507.0 |
| Jul 02, 2024 | 3.23 | 3.245 | 3.09 | 3.22 | 1.227M |
| Jul 01, 2024 | 3.30 | 3.39 | 3.205 | 3.26 | 1.035M |
| Jun 28, 2024 | 3.25 | 3.30 | 3.125 | 3.28 | 3.810M |
| Jun 27, 2024 | 3.26 | 3.345 | 3.10 | 3.265 | 1.090M |
| Jun 26, 2024 | 3.64 | 3.66 | 3.245 | 3.26 | 1.606M |
| Jun 25, 2024 | 3.83 | 3.93 | 3.72 | 3.72 | 802410.0 |
| Jun 24, 2024 | 3.76 | 3.98 | 3.76 | 3.84 | 1.298M |
| Jun 21, 2024 | 3.65 | 3.81 | 3.61 | 3.76 | 8.304M |
| Jun 20, 2024 | 3.41 | 3.67 | 3.30 | 3.59 | 2.558M |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
1.65
Minimum
Oct 27 2023
117.40
Maximum
Jan 14 2021
31.80
Average
24.20
Median
Price Benchmarks
| NovaBay Pharmaceuticals Inc | 0.7149 |
| Palatin Technologies Inc | 1.66 |
| iBio Inc | 2.21 |
| Theriva Biologics Inc | 0.276 |
| Oragenics Inc | 1.05 |
Price Related Metrics
| PS Ratio | 83.13 |
| Price to Book Value | 1.451 |
| Earnings Yield | -35.36% |
| Market Cap | 618.11M |